Growth Metrics

Legend Biotech (LEGN) Raw Materials (2024 - 2025)

Legend Biotech filings provide 2 years of Raw Materials readings, the most recent being $23.2 million for Q1 2025.

  • On a quarterly basis, Raw Materials changed N/A to $23.2 million in Q1 2025 year-over-year; TTM through Mar 2025 was $23.2 million, a N/A change, with the full-year FY2024 number at $17.5 million, changed N/A from a year prior.
  • Raw Materials hit $23.2 million in Q1 2025 for Legend Biotech, up from $17.5 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $23.2 million in Q1 2025 to a low of $17.5 million in Q4 2024.